Publications by authors named "Kelly D DeMarco"

Claim this Profile
L
Loss of EHMT2 enhances NK cell-driven anti-tumor immunity through TGF-β1 suppression.
Suresh Chava, Suresh Bugide, Parmanand Malvi, Kelly D DeMarco, Boyang Ma

EMBO Mol Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer.
Katherine C Murphy, Kelly D DeMarco, Lin Zhou, Jessica Peura, Hadiya K Giwa

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations.
Wenlong Sun, Weining Weng, Jing Shi, Boyang Ma, Kelly D DeMarco

Bioconjug Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P21-positive senescent stromal cells promote prostate cancer immune suppression and progression that can be reversed by senolytic therapy.
Lin Zhou, Kelly D DeMarco, Katherine C Murphy, Zhenpeng Wu, Jinping Li

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPT1 is a negative regulator of STING signaling in cancer cells and its inhibition reactivates immune surveillance in cold tumors.
Shreya R Chowdhury, Chaitanya N Parikh, Arshia N Kaur, Kelly D DeMarco, Hadiya K Giwa

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the impact of therapy-induced senescence on NK cell phenotypes in cancer.
Shreya R Chowdhury, Katherine C Murphy, Chaitanya N Parikh, Kelly D DeMarco, Lin Zhou

Methods Cell Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.
Loretah Chibaya, Kelly D DeMarco, Christina F Lusi, Griffin I Kane, Meghan L Brassil

Sci Transl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC and p53 alterations cooperate through VEGF signaling to repress cytotoxic T cell and immunotherapy responses in prostate cancer.
Katherine C Murphy, Kelly D DeMarco, Lin Zhou, Yvette Lopez-Diaz, Yu-Jui Ho

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer.
Loretah Chibaya, Christina F Lusi, Kelly D DeMarco, Griffin I Kane, Meghan L Brassil

bioRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.
Loretah Chibaya, Katherine C Murphy, Kelly D DeMarco, Sneha Gopalan, Haibo Liu

Nat Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis